Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
We previously identified a multifunctional factor, metallothionein (MT), as a myeloid master transcription factor PU.1 suppressive target gene. We previously revealed that MT strongly suppresses all-trans retinoid acid induced acute promyelocytic leukemia (NB4) cells differentiation. In this study, we revealed that MT not only inhibits myeloid cell differentiation, but also bears activity for drug resistance, especially for cytarabine (Ara-C). We revealed that the MT over-expressed NB4 cells bears 1.5 to 2.0 times higher ED50 doses of Ara-C compared to their controls.
|